Global Cell and Gene Therapy Manufacturing Services Market Research Report 2025(Status and Outlook)
Report Overview
Gene therapy aims to treat disorders by replacing or introducing genes into cells— either inside the body (in vivo) or outside of the body (ex vivo).
This report provides a deep insight into the global Cell and Gene Therapy Manufacturing Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell and Gene Therapy Manufacturing Services Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell and Gene Therapy Manufacturing Services market in any manner.
Global Cell and Gene Therapy Manufacturing Services Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Thermo Fisher Scientific
Merck KGaA
Charles River Laboratories
Lonza
Catalent
WuXi AppTec
Takara Bio Inc
Nikon Corporation
FUJIFILM Holdings Corporation
F. Hoffmann-La Roche
Oxford Biomedica Plc
Cell and Gene Therapy Catapult
The Discovery Labs LLC
RoslinCT
JRS PHARMA
FinVector
ABL
Resilience
BioCentriq
Porton Biopharma Limited
Andelyn Biosciences
Commercializing Living Therapies
Vibalogics
Anemocyte Srl
ElevateBio
Market Segmentation (by Type)
Allogeneic
Autologous
Viral Vector
Market Segmentation (by Application)
Oncology Diseases
Cardiovascular Diseases
Orthopedic Diseases
Ophthalmology Diseases
Infectious Diseases
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cell and Gene Therapy Manufacturing Services Market
- Overview of the regional outlook of the Cell and Gene Therapy Manufacturing Services Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell and Gene Therapy Manufacturing Services Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cell and Gene Therapy Manufacturing Services
1.2 Key Market Segments
1.2.1 Cell and Gene Therapy Manufacturing Services Segment by Type
1.2.2 Cell and Gene Therapy Manufacturing Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Cell and Gene Therapy Manufacturing Services Market Overview
2.1 Global Market Overview
2.1.1 Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Cell and Gene Therapy Manufacturing Services Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Cell and Gene Therapy Manufacturing Services Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Cell and Gene Therapy Manufacturing Services Product Life Cycle
3.3 Global Cell and Gene Therapy Manufacturing Services Sales by Manufacturers (2020-2025)
3.4 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Manufacturers (2020-2025)
3.5 Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cell and Gene Therapy Manufacturing Services Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Cell and Gene Therapy Manufacturing Services Manufacturing Sites, Area Served, Product Type
3.8 Cell and Gene Therapy Manufacturing Services Market Competitive Situation and Trends
3.8.1 Cell and Gene Therapy Manufacturing Services Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cell and Gene Therapy Manufacturing Services Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Cell and Gene Therapy Manufacturing Services Industry Chain Analysis
4.1 Cell and Gene Therapy Manufacturing Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cell and Gene Therapy Manufacturing Services Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell and Gene Therapy Manufacturing Services Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Cell and Gene Therapy Manufacturing Services Market
5.7 ESG Ratings of Leading Companies
6 Global Cell and Gene Therapy Manufacturing Services Market Sales by Region
6.1 Global Cell and Gene Therapy Manufacturing Services Sales by Region
6.1.1 Global Cell and Gene Therapy Manufacturing Services Sales by Region
6.1.2 Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Region
6.2 Global Cell and Gene Therapy Manufacturing Services Market Size by Region
6.2.1 Global Cell and Gene Therapy Manufacturing Services Market Size by Region
6.2.2 Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region
7 North America Market Overview
7.1 North America Cell and Gene Therapy Manufacturing Services Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Type
7.3 North America Cell and Gene Therapy Manufacturing Services Market Size by Application
8 Europe Market Overview
8.1 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type
8.3 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type
9.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application
10 South America Market Overview
10.1 South America Cell and Gene Therapy Manufacturing Services Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Cell and Gene Therapy Manufacturing Services Market Size by Type
10.3 South America Cell and Gene Therapy Manufacturing Services Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Type
11.3 Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Application
12 Cell and Gene Therapy Manufacturing Services Market Production by Region
12.1 Global Production of Cell and Gene Therapy Manufacturing Services by Region(2020-2025)
12.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Region (2020-2025)
12.3 Global Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Cell and Gene Therapy Manufacturing Services Production
12.4.1 North America Cell and Gene Therapy Manufacturing Services Production Growth Rate (2020-2025)
12.4.2 North America Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Cell and Gene Therapy Manufacturing Services Production
12.5.1 Europe Cell and Gene Therapy Manufacturing Services Production Growth Rate (2020-2025)
12.5.2 Europe Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Cell and Gene Therapy Manufacturing Services Production (2020-2025)
12.6.1 Japan Cell and Gene Therapy Manufacturing Services Production Growth Rate (2020-2025)
12.6.2 Japan Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Cell and Gene Therapy Manufacturing Services Production (2020-2025)
12.7.1 China Cell and Gene Therapy Manufacturing Services Production Growth Rate (2020-2025)
12.7.2 China Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
13 Cell and Gene Therapy Manufacturing Services Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Type (2020-2033)
13.3 Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2020-2033)
13.4 Global Cell and Gene Therapy Manufacturing Services Price by Type (2020-2033)
14 Cell and Gene Therapy Manufacturing Services Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Cell and Gene Therapy Manufacturing Services Market Sales by Application (2020-2033)
14.3 Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2020-2033)
14.4 Global Cell and Gene Therapy Manufacturing Services Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Thermo Fisher Scientific
15.1.1 Thermo Fisher Scientific Basic Information
15.1.2 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Overview
15.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Market Performance
15.1.4 Thermo Fisher Scientific Business Overview
15.1.5 Thermo Fisher Scientific SWOT Analysis
15.1.6 Thermo Fisher Scientific Recent Developments
15.2 Merck KGaA
15.2.1 Merck KGaA Basic Information
15.2.2 Merck KGaA Cell and Gene Therapy Manufacturing Services Product Overview
15.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Product Market Performance
15.2.4 Merck KGaA Business Overview
15.2.5 Merck KGaA SWOT Analysis
15.2.6 Merck KGaA Recent Developments
15.3 Charles River Laboratories
15.3.1 Charles River Laboratories Basic Information
15.3.2 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Overview
15.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Market Performance
15.3.4 Charles River Laboratories Business Overview
15.3.5 Charles River Laboratories SWOT Analysis
15.3.6 Charles River Laboratories Recent Developments
15.4 Lonza
15.4.1 Lonza Basic Information
15.4.2 Lonza Cell and Gene Therapy Manufacturing Services Product Overview
15.4.3 Lonza Cell and Gene Therapy Manufacturing Services Product Market Performance
15.4.4 Lonza Business Overview
15.4.5 Lonza Recent Developments
15.5 Catalent
15.5.1 Catalent Basic Information
15.5.2 Catalent Cell and Gene Therapy Manufacturing Services Product Overview
15.5.3 Catalent Cell and Gene Therapy Manufacturing Services Product Market Performance
15.5.4 Catalent Business Overview
15.5.5 Catalent Recent Developments
15.6 WuXi AppTec
15.6.1 WuXi AppTec Basic Information
15.6.2 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Overview
15.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Market Performance
15.6.4 WuXi AppTec Business Overview
15.6.5 WuXi AppTec Recent Developments
15.7 Takara Bio Inc
15.7.1 Takara Bio Inc Basic Information
15.7.2 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Overview
15.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Market Performance
15.7.4 Takara Bio Inc Business Overview
15.7.5 Takara Bio Inc Recent Developments
15.8 Nikon Corporation
15.8.1 Nikon Corporation Basic Information
15.8.2 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Overview
15.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Market Performance
15.8.4 Nikon Corporation Business Overview
15.8.5 Nikon Corporation Recent Developments
15.9 FUJIFILM Holdings Corporation
15.9.1 FUJIFILM Holdings Corporation Basic Information
15.9.2 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Overview
15.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Market Performance
15.9.4 FUJIFILM Holdings Corporation Business Overview
15.9.5 FUJIFILM Holdings Corporation Recent Developments
15.10 F. Hoffmann-La Roche
15.10.1 F. Hoffmann-La Roche Basic Information
15.10.2 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Overview
15.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Market Performance
15.10.4 F. Hoffmann-La Roche Business Overview
15.10.5 F. Hoffmann-La Roche Recent Developments
15.11 Oxford Biomedica Plc
15.11.1 Oxford Biomedica Plc Basic Information
15.11.2 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Overview
15.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Market Performance
15.11.4 Oxford Biomedica Plc Business Overview
15.11.5 Oxford Biomedica Plc Recent Developments
15.12 Cell and Gene Therapy Catapult
15.12.1 Cell and Gene Therapy Catapult Basic Information
15.12.2 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Overview
15.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Market Performance
15.12.4 Cell and Gene Therapy Catapult Business Overview
15.12.5 Cell and Gene Therapy Catapult Recent Developments
15.13 The Discovery Labs LLC
15.13.1 The Discovery Labs LLC Basic Information
15.13.2 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Overview
15.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Market Performance
15.13.4 The Discovery Labs LLC Business Overview
15.13.5 The Discovery Labs LLC Recent Developments
15.14 RoslinCT
15.14.1 RoslinCT Basic Information
15.14.2 RoslinCT Cell and Gene Therapy Manufacturing Services Product Overview
15.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Product Market Performance
15.14.4 RoslinCT Business Overview
15.14.5 RoslinCT Recent Developments
15.15 JRS PHARMA
15.15.1 JRS PHARMA Basic Information
15.15.2 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Overview
15.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Market Performance
15.15.4 JRS PHARMA Business Overview
15.15.5 JRS PHARMA Recent Developments
15.16 FinVector
15.16.1 FinVector Basic Information
15.16.2 FinVector Cell and Gene Therapy Manufacturing Services Product Overview
15.16.3 FinVector Cell and Gene Therapy Manufacturing Services Product Market Performance
15.16.4 FinVector Business Overview
15.16.5 FinVector Recent Developments
15.17 ABL
15.17.1 ABL Basic Information
15.17.2 ABL Cell and Gene Therapy Manufacturing Services Product Overview
15.17.3 ABL Cell and Gene Therapy Manufacturing Services Product Market Performance
15.17.4 ABL Business Overview
15.17.5 ABL Recent Developments
15.18 Resilience
15.18.1 Resilience Basic Information
15.18.2 Resilience Cell and Gene Therapy Manufacturing Services Product Overview
15.18.3 Resilience Cell and Gene Therapy Manufacturing Services Product Market Performance
15.18.4 Resilience Business Overview
15.18.5 Resilience Recent Developments
15.19 BioCentriq
15.19.1 BioCentriq Basic Information
15.19.2 BioCentriq Cell and Gene Therapy Manufacturing Services Product Overview
15.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Product Market Performance
15.19.4 BioCentriq Business Overview
15.19.5 BioCentriq Recent Developments
15.20 Porton Biopharma Limited
15.20.1 Porton Biopharma Limited Basic Information
15.20.2 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Overview
15.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Market Performance
15.20.4 Porton Biopharma Limited Business Overview
15.20.5 Porton Biopharma Limited Recent Developments
15.21 Andelyn Biosciences
15.21.1 Andelyn Biosciences Basic Information
15.21.2 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Overview
15.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Market Performance
15.21.4 Andelyn Biosciences Business Overview
15.21.5 Andelyn Biosciences Recent Developments
15.22 Commercializing Living Therapies
15.22.1 Commercializing Living Therapies Basic Information
15.22.2 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Overview
15.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Market Performance
15.22.4 Commercializing Living Therapies Business Overview
15.22.5 Commercializing Living Therapies Recent Developments
15.23 Vibalogics
15.23.1 Vibalogics Basic Information
15.23.2 Vibalogics Cell and Gene Therapy Manufacturing Services Product Overview
15.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Product Market Performance
15.23.4 Vibalogics Business Overview
15.23.5 Vibalogics Recent Developments
15.24 Anemocyte Srl
15.24.1 Anemocyte Srl Basic Information
15.24.2 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Overview
15.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Market Performance
15.24.4 Anemocyte Srl Business Overview
15.24.5 Anemocyte Srl Recent Developments
15.25 ElevateBio
15.25.1 ElevateBio Basic Information
15.25.2 ElevateBio Cell and Gene Therapy Manufacturing Services Product Overview
15.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Product Market Performance
15.25.4 ElevateBio Business Overview
15.25.5 ElevateBio Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell and Gene Therapy Manufacturing Services Market Size Comparison by Region (M USD)
Table 5. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Cell and Gene Therapy Manufacturing Services Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Services as of 2024)
Table 10. Global Market Cell and Gene Therapy Manufacturing Services Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Cell and Gene Therapy Manufacturing Services Manufacturing Sites and Area Served
Table 12. Manufacturers Cell and Gene Therapy Manufacturing Services Product Type
Table 13. Global Cell and Gene Therapy Manufacturing Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Cell and Gene Therapy Manufacturing Services Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Cell and Gene Therapy Manufacturing Services Sales by Region (2020-2025) & (K Units)
Table 25. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Region (2020-2025)
Table 26. Global Cell and Gene Therapy Manufacturing Services Market Size by Region (2020-2025) & (M USD)
Table 27. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region (2020-2025)
Table 28. North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2020-2033) & (M USD)
Table 29. North America Cell and Gene Therapy Manufacturing Services Sales by Country (2020-2033) & (K Units)
Table 30. North America Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 31. North America Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 32. North America Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2020-2033)
Table 33. North America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2020-2033)
Table 34. North America Cell and Gene Therapy Manufacturing Services Sales by Application (K Units)
Table 35. North America Cell and Gene Therapy Manufacturing Services Market Size by Application (M USD)
Table 36. North America Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application (2020-2033)
Table 37. North America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2020-2033)
Table 38. Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2020-2033) & (M USD)
Table 39. Europe Cell and Gene Therapy Manufacturing Services Sales by Country (2020-2033) & (K Units)
Table 40. Europe Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 41. Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 42. Europe Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2020-2033)
Table 43. Europe Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2020-2033)
Table 44. Europe Cell and Gene Therapy Manufacturing Services Sales by Application (K Units)
Table 45. Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (M USD)
Table 46. Europe Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application (2020-2033)
Table 47. Europe Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2020-2033)
Table 48. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Country (2020-2025) & (M USD)
Table 49. Asia-Pacific Cell and Gene Therapy Manufacturing Services Sales by Country (2020-2025) & (K Units)
Table 50. Asia-Pacific Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 51. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 52. Asia-Pacific Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2020-2033)
Table 53. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2020-2025)
Table 54. Asia-Pacific Cell and Gene Therapy Manufacturing Services Sales by Application (K Units)
Table 55. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application (M USD)
Table 56. Asia-Pacific Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application (2020-2033)
Table 57. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2020-2025)
Table 58. South America Cell and Gene Therapy Manufacturing Services Market Size by Country (2020-2033) & (M USD)
Table 59. South America Cell and Gene Therapy Manufacturing Services Sales by Country (2020-2033) & (K Units)
Table 60. South America Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 61. South America Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 62. South America Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2020-2033)
Table 63. South America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2020-2033)
Table 64. South America Cell and Gene Therapy Manufacturing Services Sales by Application (K Units)
Table 65. South America Cell and Gene Therapy Manufacturing Services Market Size by Application (M USD)
Table 66. South America Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application (2020-2033)
Table 67. South America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2020-2033)
Table 68. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2020-2033) & (M USD)
Table 69. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales by Country (2020-2033) & (K Units)
Table 70. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 71. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 72. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2020-2033)
Table 73. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2020-2033)
Table 74. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales by Application (K Units)
Table 75. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (M USD)
Table 76. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application (2020-2033)
Table 77. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2020-2033)
Table 78. Global Cell and Gene Therapy Manufacturing Services Production (K Units) by Region(2020-2025)
Table 79. Global Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) by Region (2020-2025)
Table 80. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Region (2020-2025)
Table 81. Global Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. North America Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Europe Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Japan Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. China Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Global Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 87. Global Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 88. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2020-2033)
Table 89. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Type (2020-2033)
Table 90. Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2020-2033)
Table 91. Global Cell and Gene Therapy Manufacturing Services Market Size Share by Type (2020-2033)
Table 92. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application
Table 93. Global Cell and Gene Therapy Manufacturing Services Market Size by Application(M USD)
Table 94. Global Cell and Gene Therapy Manufacturing Services Sales by Application (2020-2033) & (K Units)
Table 95. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Application (2020-2033)
Table 96. Global Cell and Gene Therapy Manufacturing Services Market Size by Application (2020-2033) & (M USD)
Table 97. Global Cell and Gene Therapy Manufacturing Services Market Share by Application (2020-2033)
Table 98. Global Cell and Gene Therapy Manufacturing Services Sales Growth Rate by Application (2020-2033)
Table 99. Thermo Fisher Scientific Basic Information
Table 100. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Overview
Table 101. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Thermo Fisher Scientific Business Overview
Table 103. Thermo Fisher Scientific SWOT Analysis
Table 104. Thermo Fisher Scientific Recent Developments
Table 105. Merck KGaA Basic Information
Table 106. Merck KGaA Cell and Gene Therapy Manufacturing Services Product Overview
Table 107. Merck KGaA Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Merck KGaA Business Overview
Table 109. Merck KGaA SWOT Analysis
Table 110. Merck KGaA Recent Developments
Table 111. Charles River Laboratories Basic Information
Table 112. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Overview
Table 113. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. Charles River Laboratories Business Overview
Table 115. Charles River Laboratories SWOT Analysis
Table 116. Charles River Laboratories Recent Developments
Table 117. Lonza Basic Information
Table 118. Lonza Cell and Gene Therapy Manufacturing Services Product Overview
Table 119. Lonza Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Lonza Business Overview
Table 121. Lonza Recent Developments
Table 122. Catalent Basic Information
Table 123. Catalent Cell and Gene Therapy Manufacturing Services Product Overview
Table 124. Catalent Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Catalent Business Overview
Table 126. Catalent Recent Developments
Table 127. WuXi AppTec Basic Information
Table 128. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Overview
Table 129. WuXi AppTec Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. WuXi AppTec Business Overview
Table 131. WuXi AppTec Recent Developments
Table 132. Takara Bio Inc Basic Information
Table 133. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Overview
Table 134. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Takara Bio Inc Business Overview
Table 136. Takara Bio Inc Recent Developments
Table 137. Nikon Corporation Basic Information
Table 138. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Overview
Table 139. Nikon Corporation Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Nikon Corporation Business Overview
Table 141. Nikon Corporation Recent Developments
Table 142. FUJIFILM Holdings Corporation Basic Information
Table 143. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Overview
Table 144. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. FUJIFILM Holdings Corporation Business Overview
Table 146. FUJIFILM Holdings Corporation Recent Developments
Table 147. F. Hoffmann-La Roche Basic Information
Table 148. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Overview
Table 149. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 150. F. Hoffmann-La Roche Business Overview
Table 151. F. Hoffmann-La Roche Recent Developments
Table 152. Oxford Biomedica Plc Basic Information
Table 153. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Overview
Table 154. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 155. Oxford Biomedica Plc Business Overview
Table 156. Oxford Biomedica Plc Recent Developments
Table 157. Cell and Gene Therapy Catapult Basic Information
Table 158. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Overview
Table 159. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 160. Cell and Gene Therapy Catapult Business Overview
Table 161. Cell and Gene Therapy Catapult Recent Developments
Table 162. The Discovery Labs LLC Basic Information
Table 163. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Overview
Table 164. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 165. The Discovery Labs LLC Business Overview
Table 166. The Discovery Labs LLC Recent Developments
Table 167. RoslinCT Basic Information
Table 168. RoslinCT Cell and Gene Therapy Manufacturing Services Product Overview
Table 169. RoslinCT Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 170. RoslinCT Business Overview
Table 171. RoslinCT Recent Developments
Table 172. JRS PHARMA Basic Information
Table 173. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Overview
Table 174. JRS PHARMA Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 175. JRS PHARMA Business Overview
Table 176. JRS PHARMA Recent Developments
Table 177. FinVector Basic Information
Table 178. FinVector Cell and Gene Therapy Manufacturing Services Product Overview
Table 179. FinVector Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 180. FinVector Business Overview
Table 181. FinVector Recent Developments
Table 182. ABL Basic Information
Table 183. ABL Cell and Gene Therapy Manufacturing Services Product Overview
Table 184. ABL Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 185. ABL Business Overview
Table 186. ABL Recent Developments
Table 187. Resilience Basic Information
Table 188. Resilience Cell and Gene Therapy Manufacturing Services Product Overview
Table 189. Resilience Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 190. Resilience Business Overview
Table 191. Resilience Recent Developments
Table 192. BioCentriq Basic Information
Table 193. BioCentriq Cell and Gene Therapy Manufacturing Services Product Overview
Table 194. BioCentriq Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 195. BioCentriq Business Overview
Table 196. BioCentriq Recent Developments
Table 197. Porton Biopharma Limited Basic Information
Table 198. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Overview
Table 199. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 200. Porton Biopharma Limited Business Overview
Table 201. Porton Biopharma Limited Recent Developments
Table 202. Andelyn Biosciences Basic Information
Table 203. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Overview
Table 204. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 205. Andelyn Biosciences Business Overview
Table 206. Andelyn Biosciences Recent Developments
Table 207. Commercializing Living Therapies Basic Information
Table 208. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Overview
Table 209. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 210. Commercializing Living Therapies Business Overview
Table 211. Commercializing Living Therapies Recent Developments
Table 212. Vibalogics Basic Information
Table 213. Vibalogics Cell and Gene Therapy Manufacturing Services Product Overview
Table 214. Vibalogics Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 215. Vibalogics Business Overview
Table 216. Vibalogics Recent Developments
Table 217. Anemocyte Srl Basic Information
Table 218. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Overview
Table 219. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 220. Anemocyte Srl Business Overview
Table 221. Anemocyte Srl Recent Developments
Table 222. ElevateBio Basic Information
Table 223. ElevateBio Cell and Gene Therapy Manufacturing Services Product Overview
Table 224. ElevateBio Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 225. ElevateBio Business Overview
Table 226. ElevateBio Recent Developments
List of Figures
Figure 1. Product Picture of Cell and Gene Therapy Manufacturing Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell and Gene Therapy Manufacturing Services Market Size (M USD), 2024-2033
Figure 5. Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) (2020-2033)
Figure 6. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell and Gene Therapy Manufacturing Services Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cell and Gene Therapy Manufacturing Services Product Life Cycle
Figure 13. Cell and Gene Therapy Manufacturing Services Sales Share by Manufacturers in 2024
Figure 14. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Manufacturers in 2024
Figure 15. Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Cell and Gene Therapy Manufacturing Services Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cell and Gene Therapy Manufacturing Services Revenue in 2024
Figure 18. Industry Chain Map of Cell and Gene Therapy Manufacturing Services
Figure 19. Global Cell and Gene Therapy Manufacturing Services Market PEST Analysis
Figure 20. Global Cell and Gene Therapy Manufacturing Services Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Region (2020-2025)
Figure 26. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region (2020-2025)
Figure 27. North American Market Snapshot
Figure 28. North America Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 29. North America Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 30. North America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Country
Figure 31. USA Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 32. USA Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 33. Canada Cell and Gene Therapy Manufacturing Services Sales (K Units) and Growth Rate (2020-2033)
Figure 34. Canada Cell and Gene Therapy Manufacturing Services Market Size (M USD) and Growth Rate (2020-2033)
Figure 35. Mexico Cell and Gene Therapy Manufacturing Services Sales (Units) and Growth Rate (2020-2033)
Figure 36. Mexico Cell and Gene Therapy Manufacturing Services Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. North America Cell and Gene Therapy Manufacturing Services Market Size (M USD)by Type
Figure 38. North America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application
Figure 39. Europe Market Snapshot
Figure 40. Europe Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 41. Europe Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 42. Europe Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Country
Figure 43. Germany Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 44. Germany Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 45. France Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. France Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. U.K. Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. U.K. Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 49. Italy Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. Italy Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 51. Spain Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Spain Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Europe Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type
Figure 54. Europe Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application
Figure 55. Asia-Pacific Market Snapshot
Figure 56. Asia-Pacific Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 57. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Country
Figure 59. China Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. China Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Japan Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Japan Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. South Korea Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. South Korea Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. India Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. India Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. Southeast Asia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type
Figure 70. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application
Figure 71. South America Market Snapshot
Figure 72. South America Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 73. South America Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 74. South America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Country
Figure 75. Brazil Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 76. Brazil Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 77. Argentina Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Argentina Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Columbia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Columbia Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. South America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type
Figure 82. South America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application
Figure 83. Middle East and Africa Market Snapshot
Figure 84. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 85. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 86. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Country
Figure 87. Saudi Arabia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 88. Saudi Arabia Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 89. UAE Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. UAE Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. Egypt Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. Egypt Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Nigeria Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Nigeria Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. South Africa Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. South Africa Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type
Figure 98. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application
Figure 99. Global Cell and Gene Therapy Manufacturing Services Production Market Share by Region (2020-2025)
Figure 100. North America Cell and Gene Therapy Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 101. Europe Cell and Gene Therapy Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 102. Japan Cell and Gene Therapy Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 103. China Cell and Gene Therapy Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 104. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 105. Global Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Figure 106. Sales Market Share of Cell and Gene Therapy Manufacturing Services by Type (2020-2033)
Figure 107. Sales Market Share of Cell and Gene Therapy Manufacturing Services by Type in 2024
Figure 108. Market Size Share of Cell and Gene Therapy Manufacturing Services by Type (2020-2033)
Figure 109. Market Size Share of Cell and Gene Therapy Manufacturing Services by Type in 2024
Figure 110. Global Cell and Gene Therapy Manufacturing Services Price (USD/Unit) by Type (2020-2033)
Figure 111. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 112. Global Cell and Gene Therapy Manufacturing Services Market Size by Application(M USD)
Figure 113. Global Cell and Gene Therapy Manufacturing Services Market Share by Application
Figure 114. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Application (2020-2033)
Figure 115. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Application in 2024
Figure 116. Global Cell and Gene Therapy Manufacturing Services Market Share by Application (2020-2033)
Figure 117. Global Cell and Gene Therapy Manufacturing Services Market Share by Application in 2024
Figure 118. Global Cell and Gene Therapy Manufacturing Services Sales Growth Rate by Application (2020-2033)
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Cell and Gene Therapy Manufacturing Services
1.2 Key Market Segments
1.2.1 Cell and Gene Therapy Manufacturing Services Segment by Type
1.2.2 Cell and Gene Therapy Manufacturing Services Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Cell and Gene Therapy Manufacturing Services Market Overview
2.1 Global Market Overview
2.1.1 Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Cell and Gene Therapy Manufacturing Services Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Cell and Gene Therapy Manufacturing Services Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Cell and Gene Therapy Manufacturing Services Product Life Cycle
3.3 Global Cell and Gene Therapy Manufacturing Services Sales by Manufacturers (2020-2025)
3.4 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Manufacturers (2020-2025)
3.5 Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Cell and Gene Therapy Manufacturing Services Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Cell and Gene Therapy Manufacturing Services Manufacturing Sites, Area Served, Product Type
3.8 Cell and Gene Therapy Manufacturing Services Market Competitive Situation and Trends
3.8.1 Cell and Gene Therapy Manufacturing Services Market Concentration Rate
3.8.2 Global 5 and 10 Largest Cell and Gene Therapy Manufacturing Services Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Cell and Gene Therapy Manufacturing Services Industry Chain Analysis
4.1 Cell and Gene Therapy Manufacturing Services Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Cell and Gene Therapy Manufacturing Services Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cell and Gene Therapy Manufacturing Services Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Cell and Gene Therapy Manufacturing Services Market
5.7 ESG Ratings of Leading Companies
6 Global Cell and Gene Therapy Manufacturing Services Market Sales by Region
6.1 Global Cell and Gene Therapy Manufacturing Services Sales by Region
6.1.1 Global Cell and Gene Therapy Manufacturing Services Sales by Region
6.1.2 Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Region
6.2 Global Cell and Gene Therapy Manufacturing Services Market Size by Region
6.2.1 Global Cell and Gene Therapy Manufacturing Services Market Size by Region
6.2.2 Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region
7 North America Market Overview
7.1 North America Cell and Gene Therapy Manufacturing Services Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Cell and Gene Therapy Manufacturing Services Market Size by Type
7.3 North America Cell and Gene Therapy Manufacturing Services Market Size by Application
8 Europe Market Overview
8.1 Europe Cell and Gene Therapy Manufacturing Services Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Cell and Gene Therapy Manufacturing Services Market Size by Type
8.3 Europe Cell and Gene Therapy Manufacturing Services Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type
9.3 Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application
10 South America Market Overview
10.1 South America Cell and Gene Therapy Manufacturing Services Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Cell and Gene Therapy Manufacturing Services Market Size by Type
10.3 South America Cell and Gene Therapy Manufacturing Services Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Type
11.3 Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Application
12 Cell and Gene Therapy Manufacturing Services Market Production by Region
12.1 Global Production of Cell and Gene Therapy Manufacturing Services by Region(2020-2025)
12.2 Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Region (2020-2025)
12.3 Global Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Cell and Gene Therapy Manufacturing Services Production
12.4.1 North America Cell and Gene Therapy Manufacturing Services Production Growth Rate (2020-2025)
12.4.2 North America Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Cell and Gene Therapy Manufacturing Services Production
12.5.1 Europe Cell and Gene Therapy Manufacturing Services Production Growth Rate (2020-2025)
12.5.2 Europe Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Cell and Gene Therapy Manufacturing Services Production (2020-2025)
12.6.1 Japan Cell and Gene Therapy Manufacturing Services Production Growth Rate (2020-2025)
12.6.2 Japan Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Cell and Gene Therapy Manufacturing Services Production (2020-2025)
12.7.1 China Cell and Gene Therapy Manufacturing Services Production Growth Rate (2020-2025)
12.7.2 China Cell and Gene Therapy Manufacturing Services Production, Revenue, Price and Gross Margin (2020-2025)
13 Cell and Gene Therapy Manufacturing Services Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Type (2020-2033)
13.3 Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Type (2020-2033)
13.4 Global Cell and Gene Therapy Manufacturing Services Price by Type (2020-2033)
14 Cell and Gene Therapy Manufacturing Services Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Cell and Gene Therapy Manufacturing Services Market Sales by Application (2020-2033)
14.3 Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2020-2033)
14.4 Global Cell and Gene Therapy Manufacturing Services Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Thermo Fisher Scientific
15.1.1 Thermo Fisher Scientific Basic Information
15.1.2 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Overview
15.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Market Performance
15.1.4 Thermo Fisher Scientific Business Overview
15.1.5 Thermo Fisher Scientific SWOT Analysis
15.1.6 Thermo Fisher Scientific Recent Developments
15.2 Merck KGaA
15.2.1 Merck KGaA Basic Information
15.2.2 Merck KGaA Cell and Gene Therapy Manufacturing Services Product Overview
15.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Product Market Performance
15.2.4 Merck KGaA Business Overview
15.2.5 Merck KGaA SWOT Analysis
15.2.6 Merck KGaA Recent Developments
15.3 Charles River Laboratories
15.3.1 Charles River Laboratories Basic Information
15.3.2 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Overview
15.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Market Performance
15.3.4 Charles River Laboratories Business Overview
15.3.5 Charles River Laboratories SWOT Analysis
15.3.6 Charles River Laboratories Recent Developments
15.4 Lonza
15.4.1 Lonza Basic Information
15.4.2 Lonza Cell and Gene Therapy Manufacturing Services Product Overview
15.4.3 Lonza Cell and Gene Therapy Manufacturing Services Product Market Performance
15.4.4 Lonza Business Overview
15.4.5 Lonza Recent Developments
15.5 Catalent
15.5.1 Catalent Basic Information
15.5.2 Catalent Cell and Gene Therapy Manufacturing Services Product Overview
15.5.3 Catalent Cell and Gene Therapy Manufacturing Services Product Market Performance
15.5.4 Catalent Business Overview
15.5.5 Catalent Recent Developments
15.6 WuXi AppTec
15.6.1 WuXi AppTec Basic Information
15.6.2 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Overview
15.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Market Performance
15.6.4 WuXi AppTec Business Overview
15.6.5 WuXi AppTec Recent Developments
15.7 Takara Bio Inc
15.7.1 Takara Bio Inc Basic Information
15.7.2 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Overview
15.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Market Performance
15.7.4 Takara Bio Inc Business Overview
15.7.5 Takara Bio Inc Recent Developments
15.8 Nikon Corporation
15.8.1 Nikon Corporation Basic Information
15.8.2 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Overview
15.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Market Performance
15.8.4 Nikon Corporation Business Overview
15.8.5 Nikon Corporation Recent Developments
15.9 FUJIFILM Holdings Corporation
15.9.1 FUJIFILM Holdings Corporation Basic Information
15.9.2 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Overview
15.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Market Performance
15.9.4 FUJIFILM Holdings Corporation Business Overview
15.9.5 FUJIFILM Holdings Corporation Recent Developments
15.10 F. Hoffmann-La Roche
15.10.1 F. Hoffmann-La Roche Basic Information
15.10.2 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Overview
15.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Market Performance
15.10.4 F. Hoffmann-La Roche Business Overview
15.10.5 F. Hoffmann-La Roche Recent Developments
15.11 Oxford Biomedica Plc
15.11.1 Oxford Biomedica Plc Basic Information
15.11.2 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Overview
15.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Market Performance
15.11.4 Oxford Biomedica Plc Business Overview
15.11.5 Oxford Biomedica Plc Recent Developments
15.12 Cell and Gene Therapy Catapult
15.12.1 Cell and Gene Therapy Catapult Basic Information
15.12.2 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Overview
15.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Market Performance
15.12.4 Cell and Gene Therapy Catapult Business Overview
15.12.5 Cell and Gene Therapy Catapult Recent Developments
15.13 The Discovery Labs LLC
15.13.1 The Discovery Labs LLC Basic Information
15.13.2 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Overview
15.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Market Performance
15.13.4 The Discovery Labs LLC Business Overview
15.13.5 The Discovery Labs LLC Recent Developments
15.14 RoslinCT
15.14.1 RoslinCT Basic Information
15.14.2 RoslinCT Cell and Gene Therapy Manufacturing Services Product Overview
15.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Product Market Performance
15.14.4 RoslinCT Business Overview
15.14.5 RoslinCT Recent Developments
15.15 JRS PHARMA
15.15.1 JRS PHARMA Basic Information
15.15.2 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Overview
15.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Market Performance
15.15.4 JRS PHARMA Business Overview
15.15.5 JRS PHARMA Recent Developments
15.16 FinVector
15.16.1 FinVector Basic Information
15.16.2 FinVector Cell and Gene Therapy Manufacturing Services Product Overview
15.16.3 FinVector Cell and Gene Therapy Manufacturing Services Product Market Performance
15.16.4 FinVector Business Overview
15.16.5 FinVector Recent Developments
15.17 ABL
15.17.1 ABL Basic Information
15.17.2 ABL Cell and Gene Therapy Manufacturing Services Product Overview
15.17.3 ABL Cell and Gene Therapy Manufacturing Services Product Market Performance
15.17.4 ABL Business Overview
15.17.5 ABL Recent Developments
15.18 Resilience
15.18.1 Resilience Basic Information
15.18.2 Resilience Cell and Gene Therapy Manufacturing Services Product Overview
15.18.3 Resilience Cell and Gene Therapy Manufacturing Services Product Market Performance
15.18.4 Resilience Business Overview
15.18.5 Resilience Recent Developments
15.19 BioCentriq
15.19.1 BioCentriq Basic Information
15.19.2 BioCentriq Cell and Gene Therapy Manufacturing Services Product Overview
15.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Product Market Performance
15.19.4 BioCentriq Business Overview
15.19.5 BioCentriq Recent Developments
15.20 Porton Biopharma Limited
15.20.1 Porton Biopharma Limited Basic Information
15.20.2 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Overview
15.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Market Performance
15.20.4 Porton Biopharma Limited Business Overview
15.20.5 Porton Biopharma Limited Recent Developments
15.21 Andelyn Biosciences
15.21.1 Andelyn Biosciences Basic Information
15.21.2 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Overview
15.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Market Performance
15.21.4 Andelyn Biosciences Business Overview
15.21.5 Andelyn Biosciences Recent Developments
15.22 Commercializing Living Therapies
15.22.1 Commercializing Living Therapies Basic Information
15.22.2 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Overview
15.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Market Performance
15.22.4 Commercializing Living Therapies Business Overview
15.22.5 Commercializing Living Therapies Recent Developments
15.23 Vibalogics
15.23.1 Vibalogics Basic Information
15.23.2 Vibalogics Cell and Gene Therapy Manufacturing Services Product Overview
15.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Product Market Performance
15.23.4 Vibalogics Business Overview
15.23.5 Vibalogics Recent Developments
15.24 Anemocyte Srl
15.24.1 Anemocyte Srl Basic Information
15.24.2 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Overview
15.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Market Performance
15.24.4 Anemocyte Srl Business Overview
15.24.5 Anemocyte Srl Recent Developments
15.25 ElevateBio
15.25.1 ElevateBio Basic Information
15.25.2 ElevateBio Cell and Gene Therapy Manufacturing Services Product Overview
15.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Product Market Performance
15.25.4 ElevateBio Business Overview
15.25.5 ElevateBio Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell and Gene Therapy Manufacturing Services Market Size Comparison by Region (M USD)
Table 5. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Cell and Gene Therapy Manufacturing Services Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell and Gene Therapy Manufacturing Services as of 2024)
Table 10. Global Market Cell and Gene Therapy Manufacturing Services Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Cell and Gene Therapy Manufacturing Services Manufacturing Sites and Area Served
Table 12. Manufacturers Cell and Gene Therapy Manufacturing Services Product Type
Table 13. Global Cell and Gene Therapy Manufacturing Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Cell and Gene Therapy Manufacturing Services Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Cell and Gene Therapy Manufacturing Services Sales by Region (2020-2025) & (K Units)
Table 25. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Region (2020-2025)
Table 26. Global Cell and Gene Therapy Manufacturing Services Market Size by Region (2020-2025) & (M USD)
Table 27. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region (2020-2025)
Table 28. North America Cell and Gene Therapy Manufacturing Services Market Size by Country (2020-2033) & (M USD)
Table 29. North America Cell and Gene Therapy Manufacturing Services Sales by Country (2020-2033) & (K Units)
Table 30. North America Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 31. North America Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 32. North America Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2020-2033)
Table 33. North America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2020-2033)
Table 34. North America Cell and Gene Therapy Manufacturing Services Sales by Application (K Units)
Table 35. North America Cell and Gene Therapy Manufacturing Services Market Size by Application (M USD)
Table 36. North America Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application (2020-2033)
Table 37. North America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2020-2033)
Table 38. Europe Cell and Gene Therapy Manufacturing Services Market Size by Country (2020-2033) & (M USD)
Table 39. Europe Cell and Gene Therapy Manufacturing Services Sales by Country (2020-2033) & (K Units)
Table 40. Europe Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 41. Europe Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 42. Europe Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2020-2033)
Table 43. Europe Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2020-2033)
Table 44. Europe Cell and Gene Therapy Manufacturing Services Sales by Application (K Units)
Table 45. Europe Cell and Gene Therapy Manufacturing Services Market Size by Application (M USD)
Table 46. Europe Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application (2020-2033)
Table 47. Europe Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2020-2033)
Table 48. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Country (2020-2025) & (M USD)
Table 49. Asia-Pacific Cell and Gene Therapy Manufacturing Services Sales by Country (2020-2025) & (K Units)
Table 50. Asia-Pacific Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 51. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 52. Asia-Pacific Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2020-2033)
Table 53. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2020-2025)
Table 54. Asia-Pacific Cell and Gene Therapy Manufacturing Services Sales by Application (K Units)
Table 55. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size by Application (M USD)
Table 56. Asia-Pacific Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application (2020-2033)
Table 57. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2020-2025)
Table 58. South America Cell and Gene Therapy Manufacturing Services Market Size by Country (2020-2033) & (M USD)
Table 59. South America Cell and Gene Therapy Manufacturing Services Sales by Country (2020-2033) & (K Units)
Table 60. South America Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 61. South America Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 62. South America Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2020-2033)
Table 63. South America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2020-2033)
Table 64. South America Cell and Gene Therapy Manufacturing Services Sales by Application (K Units)
Table 65. South America Cell and Gene Therapy Manufacturing Services Market Size by Application (M USD)
Table 66. South America Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application (2020-2033)
Table 67. South America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2020-2033)
Table 68. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Country (2020-2033) & (M USD)
Table 69. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales by Country (2020-2033) & (K Units)
Table 70. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 71. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 72. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2020-2033)
Table 73. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2020-2033)
Table 74. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales by Application (K Units)
Table 75. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size by Application (M USD)
Table 76. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application (2020-2033)
Table 77. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application (2020-2033)
Table 78. Global Cell and Gene Therapy Manufacturing Services Production (K Units) by Region(2020-2025)
Table 79. Global Cell and Gene Therapy Manufacturing Services Revenue (US$ Million) by Region (2020-2025)
Table 80. Global Cell and Gene Therapy Manufacturing Services Revenue Market Share by Region (2020-2025)
Table 81. Global Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. North America Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Europe Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Japan Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. China Cell and Gene Therapy Manufacturing Services Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Global Cell and Gene Therapy Manufacturing Services Sales by Type (K Units)
Table 87. Global Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Table 88. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) by Type (2020-2033)
Table 89. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Type (2020-2033)
Table 90. Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type (2020-2033)
Table 91. Global Cell and Gene Therapy Manufacturing Services Market Size Share by Type (2020-2033)
Table 92. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) by Application
Table 93. Global Cell and Gene Therapy Manufacturing Services Market Size by Application(M USD)
Table 94. Global Cell and Gene Therapy Manufacturing Services Sales by Application (2020-2033) & (K Units)
Table 95. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Application (2020-2033)
Table 96. Global Cell and Gene Therapy Manufacturing Services Market Size by Application (2020-2033) & (M USD)
Table 97. Global Cell and Gene Therapy Manufacturing Services Market Share by Application (2020-2033)
Table 98. Global Cell and Gene Therapy Manufacturing Services Sales Growth Rate by Application (2020-2033)
Table 99. Thermo Fisher Scientific Basic Information
Table 100. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Overview
Table 101. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Thermo Fisher Scientific Business Overview
Table 103. Thermo Fisher Scientific SWOT Analysis
Table 104. Thermo Fisher Scientific Recent Developments
Table 105. Merck KGaA Basic Information
Table 106. Merck KGaA Cell and Gene Therapy Manufacturing Services Product Overview
Table 107. Merck KGaA Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Merck KGaA Business Overview
Table 109. Merck KGaA SWOT Analysis
Table 110. Merck KGaA Recent Developments
Table 111. Charles River Laboratories Basic Information
Table 112. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Overview
Table 113. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. Charles River Laboratories Business Overview
Table 115. Charles River Laboratories SWOT Analysis
Table 116. Charles River Laboratories Recent Developments
Table 117. Lonza Basic Information
Table 118. Lonza Cell and Gene Therapy Manufacturing Services Product Overview
Table 119. Lonza Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Lonza Business Overview
Table 121. Lonza Recent Developments
Table 122. Catalent Basic Information
Table 123. Catalent Cell and Gene Therapy Manufacturing Services Product Overview
Table 124. Catalent Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Catalent Business Overview
Table 126. Catalent Recent Developments
Table 127. WuXi AppTec Basic Information
Table 128. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Overview
Table 129. WuXi AppTec Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. WuXi AppTec Business Overview
Table 131. WuXi AppTec Recent Developments
Table 132. Takara Bio Inc Basic Information
Table 133. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Overview
Table 134. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Takara Bio Inc Business Overview
Table 136. Takara Bio Inc Recent Developments
Table 137. Nikon Corporation Basic Information
Table 138. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Overview
Table 139. Nikon Corporation Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Nikon Corporation Business Overview
Table 141. Nikon Corporation Recent Developments
Table 142. FUJIFILM Holdings Corporation Basic Information
Table 143. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Overview
Table 144. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. FUJIFILM Holdings Corporation Business Overview
Table 146. FUJIFILM Holdings Corporation Recent Developments
Table 147. F. Hoffmann-La Roche Basic Information
Table 148. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Overview
Table 149. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 150. F. Hoffmann-La Roche Business Overview
Table 151. F. Hoffmann-La Roche Recent Developments
Table 152. Oxford Biomedica Plc Basic Information
Table 153. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Overview
Table 154. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 155. Oxford Biomedica Plc Business Overview
Table 156. Oxford Biomedica Plc Recent Developments
Table 157. Cell and Gene Therapy Catapult Basic Information
Table 158. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Overview
Table 159. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 160. Cell and Gene Therapy Catapult Business Overview
Table 161. Cell and Gene Therapy Catapult Recent Developments
Table 162. The Discovery Labs LLC Basic Information
Table 163. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Overview
Table 164. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 165. The Discovery Labs LLC Business Overview
Table 166. The Discovery Labs LLC Recent Developments
Table 167. RoslinCT Basic Information
Table 168. RoslinCT Cell and Gene Therapy Manufacturing Services Product Overview
Table 169. RoslinCT Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 170. RoslinCT Business Overview
Table 171. RoslinCT Recent Developments
Table 172. JRS PHARMA Basic Information
Table 173. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Overview
Table 174. JRS PHARMA Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 175. JRS PHARMA Business Overview
Table 176. JRS PHARMA Recent Developments
Table 177. FinVector Basic Information
Table 178. FinVector Cell and Gene Therapy Manufacturing Services Product Overview
Table 179. FinVector Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 180. FinVector Business Overview
Table 181. FinVector Recent Developments
Table 182. ABL Basic Information
Table 183. ABL Cell and Gene Therapy Manufacturing Services Product Overview
Table 184. ABL Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 185. ABL Business Overview
Table 186. ABL Recent Developments
Table 187. Resilience Basic Information
Table 188. Resilience Cell and Gene Therapy Manufacturing Services Product Overview
Table 189. Resilience Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 190. Resilience Business Overview
Table 191. Resilience Recent Developments
Table 192. BioCentriq Basic Information
Table 193. BioCentriq Cell and Gene Therapy Manufacturing Services Product Overview
Table 194. BioCentriq Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 195. BioCentriq Business Overview
Table 196. BioCentriq Recent Developments
Table 197. Porton Biopharma Limited Basic Information
Table 198. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Overview
Table 199. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 200. Porton Biopharma Limited Business Overview
Table 201. Porton Biopharma Limited Recent Developments
Table 202. Andelyn Biosciences Basic Information
Table 203. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Overview
Table 204. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 205. Andelyn Biosciences Business Overview
Table 206. Andelyn Biosciences Recent Developments
Table 207. Commercializing Living Therapies Basic Information
Table 208. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Overview
Table 209. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 210. Commercializing Living Therapies Business Overview
Table 211. Commercializing Living Therapies Recent Developments
Table 212. Vibalogics Basic Information
Table 213. Vibalogics Cell and Gene Therapy Manufacturing Services Product Overview
Table 214. Vibalogics Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 215. Vibalogics Business Overview
Table 216. Vibalogics Recent Developments
Table 217. Anemocyte Srl Basic Information
Table 218. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Overview
Table 219. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 220. Anemocyte Srl Business Overview
Table 221. Anemocyte Srl Recent Developments
Table 222. ElevateBio Basic Information
Table 223. ElevateBio Cell and Gene Therapy Manufacturing Services Product Overview
Table 224. ElevateBio Cell and Gene Therapy Manufacturing Services Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 225. ElevateBio Business Overview
Table 226. ElevateBio Recent Developments
List of Figures
Figure 1. Product Picture of Cell and Gene Therapy Manufacturing Services
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell and Gene Therapy Manufacturing Services Market Size (M USD), 2024-2033
Figure 5. Global Cell and Gene Therapy Manufacturing Services Market Size (M USD) (2020-2033)
Figure 6. Global Cell and Gene Therapy Manufacturing Services Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell and Gene Therapy Manufacturing Services Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Cell and Gene Therapy Manufacturing Services Product Life Cycle
Figure 13. Cell and Gene Therapy Manufacturing Services Sales Share by Manufacturers in 2024
Figure 14. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Manufacturers in 2024
Figure 15. Cell and Gene Therapy Manufacturing Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Cell and Gene Therapy Manufacturing Services Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Cell and Gene Therapy Manufacturing Services Revenue in 2024
Figure 18. Industry Chain Map of Cell and Gene Therapy Manufacturing Services
Figure 19. Global Cell and Gene Therapy Manufacturing Services Market PEST Analysis
Figure 20. Global Cell and Gene Therapy Manufacturing Services Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Region (2020-2025)
Figure 26. Global Cell and Gene Therapy Manufacturing Services Market Size Market Share by Region (2020-2025)
Figure 27. North American Market Snapshot
Figure 28. North America Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 29. North America Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 30. North America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Country
Figure 31. USA Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 32. USA Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 33. Canada Cell and Gene Therapy Manufacturing Services Sales (K Units) and Growth Rate (2020-2033)
Figure 34. Canada Cell and Gene Therapy Manufacturing Services Market Size (M USD) and Growth Rate (2020-2033)
Figure 35. Mexico Cell and Gene Therapy Manufacturing Services Sales (Units) and Growth Rate (2020-2033)
Figure 36. Mexico Cell and Gene Therapy Manufacturing Services Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. North America Cell and Gene Therapy Manufacturing Services Market Size (M USD)by Type
Figure 38. North America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application
Figure 39. Europe Market Snapshot
Figure 40. Europe Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 41. Europe Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 42. Europe Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Country
Figure 43. Germany Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 44. Germany Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 45. France Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. France Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. U.K. Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. U.K. Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 49. Italy Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. Italy Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 51. Spain Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Spain Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Europe Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type
Figure 54. Europe Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application
Figure 55. Asia-Pacific Market Snapshot
Figure 56. Asia-Pacific Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 57. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Country
Figure 59. China Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. China Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Japan Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Japan Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. South Korea Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. South Korea Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. India Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. India Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. Southeast Asia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type
Figure 70. Asia-Pacific Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application
Figure 71. South America Market Snapshot
Figure 72. South America Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 73. South America Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 74. South America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Country
Figure 75. Brazil Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 76. Brazil Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 77. Argentina Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Argentina Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Columbia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Columbia Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. South America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type
Figure 82. South America Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application
Figure 83. Middle East and Africa Market Snapshot
Figure 84. Middle East and Africa Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 85. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 86. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Country
Figure 87. Saudi Arabia Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 88. Saudi Arabia Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 89. UAE Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. UAE Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. Egypt Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. Egypt Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Nigeria Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Nigeria Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. South Africa Cell and Gene Therapy Manufacturing Services Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. South Africa Cell and Gene Therapy Manufacturing Services Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Type
Figure 98. Middle East and Africa Cell and Gene Therapy Manufacturing Services Market Size (M USD) by Application
Figure 99. Global Cell and Gene Therapy Manufacturing Services Production Market Share by Region (2020-2025)
Figure 100. North America Cell and Gene Therapy Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 101. Europe Cell and Gene Therapy Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 102. Japan Cell and Gene Therapy Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 103. China Cell and Gene Therapy Manufacturing Services Production (K Units) Growth Rate (2020-2025)
Figure 104. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 105. Global Cell and Gene Therapy Manufacturing Services Market Size by Type (M USD)
Figure 106. Sales Market Share of Cell and Gene Therapy Manufacturing Services by Type (2020-2033)
Figure 107. Sales Market Share of Cell and Gene Therapy Manufacturing Services by Type in 2024
Figure 108. Market Size Share of Cell and Gene Therapy Manufacturing Services by Type (2020-2033)
Figure 109. Market Size Share of Cell and Gene Therapy Manufacturing Services by Type in 2024
Figure 110. Global Cell and Gene Therapy Manufacturing Services Price (USD/Unit) by Type (2020-2033)
Figure 111. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 112. Global Cell and Gene Therapy Manufacturing Services Market Size by Application(M USD)
Figure 113. Global Cell and Gene Therapy Manufacturing Services Market Share by Application
Figure 114. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Application (2020-2033)
Figure 115. Global Cell and Gene Therapy Manufacturing Services Sales Market Share by Application in 2024
Figure 116. Global Cell and Gene Therapy Manufacturing Services Market Share by Application (2020-2033)
Figure 117. Global Cell and Gene Therapy Manufacturing Services Market Share by Application in 2024
Figure 118. Global Cell and Gene Therapy Manufacturing Services Sales Growth Rate by Application (2020-2033)
